Simvastatin exhibited greater cytotoxicity against MDA-MB-231 cells, a type of triple-negative breast cancer model, than MCF-7 cells, a type of normal breast cancer, due to higher HMG-CoA-reductase expression. The gene discussed is HMGCR; the disease is breast carcinoma.